Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

162
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
162
  1. Home
  3. Research Domains
  5. Biomedical And Clinical Sciences
  7. Oncology And Carcinogenesis
  9. Predictive And Prognostic Markers
  11. Stage Iv Ovarian Cancer Prognosis Nomogram And Analysis Of Racial Differences: A Study Based On The Seer Database

Stage IV ovarian cancer prognosis nomogram and analysis of racial differences: A study based on the SEER database

Guilan Wu1, Jiana Chen1, Peiguang Niu1

  • 1Department of Pharmacy, Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, 350001, China.

Heliyon
|September 12, 2024

Related Experiment Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

226
Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.7K

View abstract on PubMed

Summary
This summary is machine-generated.

This study developed a new model to predict overall survival (OS) for stage IV ovarian cancer patients. The tool helps clinicians assess prognosis and offers a risk classification system.

Area of Science:

  • Oncology
  • Biostatistics

Background:

  • Stage IV ovarian cancer presents a poor prognosis with limited predictive models.
  • Accurate prognostic tools are crucial for guiding treatment decisions.

Purpose of the Study:

  • To construct and validate a predictive model for overall survival (OS) in newly diagnosed stage IV ovarian cancer patients.
  • To develop a risk classification system to aid clinical prognosis evaluation.

Main Methods:

  • Utilized data from the SEER database for 6062 patients.
  • Employed Cox regression analysis to build a nomogram model.
  • Validated the model using C-index, calibration curves, ROC, and DCA.

Main Results:

  • Identified age, race, histological grade, T stage, CA125, liver metastasis, surgery, and chemotherapy as independent prognostic factors.
Keywords:
NomogramOvarian cancerOverall survival rateRisk stratification

Related Experiment Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

226
Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.7K
  • Achieved a C-index of 0.704 (training) and 0.711 (validation).
  • Developed an online tool (Alfalfa-IVOC-OS) and a risk classification system. Asian or Pacific Islander patients showed higher survival rates.

    • Conclusions:

    • Established a novel survival prediction model and risk stratification system for stage IV ovarian cancer.
    • The model and system assist clinicians in predicting OS and evaluating patient prognosis.
    • Highlights potential survival disparities among different racial groups.
    SEER